Presentation is loading. Please wait.

Presentation is loading. Please wait.

Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial  Hywel C. Williams,

Similar presentations


Presentation on theme: "Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial  Hywel C. Williams,"— Presentation transcript:

1 Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial  Hywel C. Williams, Fiona Bath-Hextall, Mara Ozolins, Sarah J. Armstrong, Graham B. Colver, William Perkins, Paul S.J. Miller  Journal of Investigative Dermatology  Volume 137, Issue 3, Pages (March 2017) DOI: /j.jid Copyright © 2016 The Authors Terms and Conditions

2 Figure 1 Flow of participants in the SINS trial from randomization until year 5. CONSORT flow diagram for SINS 5-year data. Journal of Investigative Dermatology  , DOI: ( /j.jid ) Copyright © 2016 The Authors Terms and Conditions


Download ppt "Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial  Hywel C. Williams,"

Similar presentations


Ads by Google